ClinicalTrials.gov
ClinicalTrials.gov Menu

Implanted Loop Recorder Post Atrial Fibrillation Ablation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00915720
Recruitment Status : Unknown
Verified July 2010 by Thoracic & Cardiovascular Healthcare Foundation.
Recruitment status was:  Active, not recruiting
First Posted : June 8, 2009
Last Update Posted : July 20, 2011
Sponsor:
Collaborators:
Medtronic
AtriCure, Inc.
Information provided by:
Thoracic & Cardiovascular Healthcare Foundation

Brief Summary:
This is a pilot study to determine if implanted loop recorders can more effectively monitor atrial fibrillation recurrence after atrial fibrillation ablation.

Condition or disease
Atrial Fibrillation

Detailed Description:

Atrial Fibrillation (AF)is the most common arrhythmia and causes significant morbidity and mortality. Treatment for AF consists of medical therapy and ablation therapy. Medical therapies can help approximately 50% of patients, the rest must resort to ablation procedures.

Ablation procedures aim to isolate the pulmonary vein from the atrial tissue electrically and can be performed either endocardially through catheters inserted through the femoral veins or epicardially through a minimal lateral thoracotomy. Both procedures are accepted as standard of care.

Recurrent AF after ablation therapy can be common and occurs in 50% of patients and could be in a form of short periods of AF or persistent AF with less or minimal symptoms. This is of significant clinical relevance as most of these AF episodes are not recognized and can lead to thromboembolic events such as stroke. However, techniques of surveillance of AF post ablation have been suboptimal. Physicians could use holter monitoring but this is limited to a short period of 24 - 48 hours. Event recorders which are external can be used but patients need to experience symptoms associated with the AF episodes in order to record the episodes.

Better AF monitoring techniques especially after AF ablation are necessary so that recognition of AF recurrence in these patient could be possible and timely anticoagulation therapy initiated may prevent strokes.

This pilot study involves implanting a loop recorder just under the skin to record cardiac rhythms 24 hours per day without any interaction by the patient. These devices are currently approved by the FDA for monitoring of syncope and will be implanted during the patients AF ablation surgery.


Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Implanted Loop Recorder Surveillance of Recurrent Atrial Fibrillation After Atrial Fibrillation Ablation
Study Start Date : August 2008
Estimated Primary Completion Date : December 2011
Estimated Study Completion Date : December 2012

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Incidence/Duration of atrial and tachyarrhythmias post AF ablation [ Time Frame: 14 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing surgical atrial fibrillation
Criteria

Inclusion Criteria:

  • Patients undergoing surgical atrial fibrillation ablation
  • Patients must be 18 years or older

Exclusion Criteria:

  • Patients unwilling to comply with the follow up schedule
  • Pregnant or breastfeeding patients
  • Patients currently participating in another study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00915720


Locations
United States, Michigan
Thoracic & Cardiovascular Healthcare Foundation
Lansing, Michigan, United States, 48910
Sponsors and Collaborators
Thoracic & Cardiovascular Healthcare Foundation
Medtronic
AtriCure, Inc.
Investigators
Principal Investigator: John H Ip, MD Thoracic & Cardiovascular Healthcare Foundation

Responsible Party: John H. Ip, MD FACC, Thoracic & Cardiovascular Healthcare Foundation
ClinicalTrials.gov Identifier: NCT00915720     History of Changes
Other Study ID Numbers: ILR 1208
First Posted: June 8, 2009    Key Record Dates
Last Update Posted: July 20, 2011
Last Verified: July 2010

Keywords provided by Thoracic & Cardiovascular Healthcare Foundation:
Atrial Fibrillation
Surgical Ablation
Implanted loop recorder
Atrial Fibrillation Ablation

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes